Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-041304

Director bought 81,250 shares at $16.00 ($1,300,000)

  • Director acquired 5,595,238 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LEVIN MARK J Director 2019-07-22 Conversion +5,595,238 5,880,952 I: show line 1 in the form
LEVIN MARK J Director 2019-07-22 Purchase +81,250 $16.00 $1,300,000 5,962,202 I: show line 2 in the form
Open-market purchases · 81,250 sh · avg $16.00 · $1,300,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
LEVIN MARK J Director 2019-07-22 Conversion · Series A Preferred Stock −39,166,667 0 I: show line 3 in the form
Loading xslF345X03/a4.xml…